Oncolytics Biotech Inc.

Oncolytics Biotech Inc. - Current Ratioverified

ONCY

Price:

$0.96

Market Cap:

$136.49M

Oncolytics Biotech Inc. is a biopharmaceutical firm in its development phase, concentrating its efforts on discovering and creating novel pharmaceutical agents to combat cancer. Its primary therapeutic candidate is pelareorep, an immunotherapeutic drug delivered intravenously, designed to target and treat both solid tumors and various blood-related cancers. The company has established strategic co-development agreements with major pharmaceutical companies, Merck KGaA and Pfizer Inc., as well as with PrECOG LLC. These collaborations are focused on advancing pelareorep for use in conjunction with paclitaxel and avelumab (a human anti-PD-L1 antibody). This specific combination therapy is being ...[Read more]

Industry

Biotechnology

IPO Date

2001-10-05

Stock Exchange

NASDAQ

Ticker

ONCY

The Current Ratio as of June 2026 (TTM) for Oncolytics Biotech Inc. (ONCY) is 1.38

According to Oncolytics Biotech Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.38. This represents a change of -23.50% compared to the average of 1.80 of the last 4 quarters.

Oncolytics Biotech Inc. (ONCY) Historical Current Ratio (quarterly & annually)

How has ONCY Current Ratio performed in the past?

The mean historical Current Ratio of Oncolytics Biotech Inc. over the last ten years is 6.47. The current 1.38 Current Ratio has changed 2.03% with respect to the historical average. Over the past ten years (40 quarters), ONCY's Current Ratio was at its highest in in the March 2021 quarter at 22.15. The Current Ratio was at its lowest in in the December 2025 quarter at 1.12.

Quarterly (TTM)
Annual

Average

6.47

Median

4.34

Minimum

1.12

Maximum

16.69

Oncolytics Biotech Inc. (ONCY) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Oncolytics Biotech Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 746.56%

Maximum Annual Current Ratio = 16.69

Minimum Annual Increase = -71.35%

Minimum Annual Current Ratio = 1.12

Quarterly (TTM)
Annual
YearCurrent RatioChange
20251.12-60.26%
20242.82-68.67%
20239.01-0.40%
20229.05-45.81%
202116.6934.05%
202012.45746.56%
20191.47-71.35%
20185.1350.72%
20173.41-3.99%
20163.55-64.29%

Oncolytics Biotech Inc. (ONCY) Average Current Ratio

How has ONCY Current Ratio performed in the past?

The current Current Ratio of Oncolytics Biotech Inc. (ONCY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.32

5-year avg

7.74

10-year avg

6.47

Oncolytics Biotech Inc. (ONCY) Current Ratio vs. Peers

How is ONCY’s Current Ratio compared to its peers?

Oncolytics Biotech Inc.’s Current Ratio is less than Atossa Therapeutics, Inc. (4.92), less than Immix Biopharma, Inc. (8.76), less than Whitehawk Therapeutics Inc (11.36), less than Instil Bio, Inc. (39.87), less than Zentalis Pharmaceuticals, Inc. (6.19), less than MacroGenics, Inc. (1.90), greater than Tevogen Bio Holdings Inc. (0.29), less than Coya Therapeutics, Inc. (15.02), less than Clene Inc. (1.94), less than Surrozen, Inc. (11.91),

Build a custom stock screener for Oncolytics Biotech Inc. (ONCY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oncolytics Biotech Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Oncolytics Biotech Inc. (ONCY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Oncolytics Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Oncolytics Biotech Inc.'s Current Ratio?

How is the Current Ratio calculated for Oncolytics Biotech Inc. (ONCY)?

What is the highest Current Ratio for Oncolytics Biotech Inc. (ONCY)?

What is the 3-year average Current Ratio for Oncolytics Biotech Inc. (ONCY)?

What is the 5-year average Current Ratio for Oncolytics Biotech Inc. (ONCY)?

How does the current Current Ratio for Oncolytics Biotech Inc. (ONCY) compare to its historical average?